Cys(11)-cys(15)-endothelin-1 (11-21) is a cyclic peptide fragment formed through intramolecular disulfide bonding that stabilizes structural motifs. Its sequence supports modeling of endothelin-receptor interactions. Hydrophobic elements influence folding. Researchers apply it in structural exploration of endothelin peptides.
CAT No: E09061
CAS No:144602-02-8
Synonyms/Alias:Irl-1038;Cys(11)-Cys(15)-endothelin-1 (11-21);144602-02-8;Endothelin-1 (11-21), cys(11)-cys(15)-;Irl 1038;Endothelin-1(11-21), cysteinyl(11)-cysteine(15)-;Endothelin 1 (pig reduced), 1-de-L-cysteine-2-de-L-serine-3-de-L-cysteine-4-de-L-serine-5-de-L-serine-6-de-L-leucine-7-de-L-methionine-8-de-L-aspartic acid-9-de-L-lysine-10-de-L-glutamic acid-, cyclic (11-15)-disulfide;Endothelin-1 (11-21) trifluoroacetate salt;DA-52896;Endothelin 1-(pig reduced), 1-de-L-cysteine-2-de-L-serine-3-de-L-cysteine-4-de-L-serine-5-de-L-serine-6-de-L-leucine-7-de-L-methionine-8-de-L-aspartic acid-9-de-L-lysine-10-de-L-glutamic acid-, cyclic (11-15)-disulfide;
2. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
3. Implications of ligand-receptor binding kinetics on GLP-1R signalling
5. Emu oil in combination with other active ingredients for treating skin imperfections
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More